PEGS Boston 2017 | The Promise of Neoantigens for Personalized Cancer Vaccines

from CHI Podcasts · host Cambridge Healthtech Podcasts

Philip Arlen from Precision Biologics recently spoke with CHI. He will be speaking at PEGS in the Adoptive T Cell Therapy conference on May 3rd 2017. Precision Biologics is working with cancer vaccines to develop personalized cancer treatments that target tumors without damaging healthy human tissues. For more information, please visit http://www.PEGSummit.com/TCellTherapy/

Episode metadata supplied by the publisher feed · Published Jan 25, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

PEGS Boston 2017 | The Promise of Neoantigens for Personalized Cancer Vaccines

0:00 6:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CHI Podcasts?

This episode is 6 minutes long.

When was this CHI Podcasts episode published?

This episode was published on January 25, 2017.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!